| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/10/2008 | WO2008040649A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 04/10/2008 | WO2008040560A1 Process for the preparation of memantine and its hydrochloric acid salt form |
| 04/10/2008 | WO2008040548A2 Treatment for non-alcoholic-steatohepatitis |
| 04/10/2008 | WO2008040547A1 Substituted indeno[1,2-b]indole derivatives as novel inhibitors of protein kinase ck2 and their use as tumour therapeutic agents, cytostatics and diagnostic aids |
| 04/10/2008 | WO2008040534A2 Non-mucoadhesive film dosage forms |
| 04/10/2008 | WO2008040488A1 Controlled release delivery system for nasal application of neurotransmitters |
| 04/10/2008 | WO2008040481A1 MIXED ORL 1/μ AGONISTS FOR TREATING PAIN |
| 04/10/2008 | WO2008040441A2 Silicon derivatives for pet imaging |
| 04/10/2008 | WO2008040367A1 Lercanidipine hydrobromide, a process for its preparation, crystalline forms and compositions thereof |
| 04/10/2008 | WO2008040361A2 Use of a combination of hypothermia inducing drugs |
| 04/10/2008 | WO2008040360A2 Use of hypothermia inducing drugs to treat ischemia |
| 04/10/2008 | WO2008040332A1 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 04/10/2008 | WO2008040236A1 Flavones derivatives, preparation methods and uses thereof |
| 04/10/2008 | WO2008040208A1 (2z)-2-(3,4-dihydroxybenzylidene)-1-benzofuran-3(2h)-one in manufacture of medicaments for treating cancers |
| 04/10/2008 | WO2008040192A1 13,13a-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE |
| 04/10/2008 | WO2008040187A1 Application of astilbin in preparation of medicament for treating or preventing acute or chronic renal failure, kidney fibrosis and diabetic renopathy |
| 04/10/2008 | WO2008040153A1 Application of a coumarin compound in preparation of medicament for inducing nerve stem cell orienting differentiation |
| 04/10/2008 | WO2008040149A1 Composition and method for treating immune-mediated skin disorders |
| 04/10/2008 | WO2008040097A1 Furanone compounds and lactam analogues thereof |
| 04/10/2008 | WO2008040094A1 Particle formation |
| 04/10/2008 | WO2008040058A1 Novel chromenone potassium channel blockers and uses thereof |
| 04/10/2008 | WO2008040057A1 Novel benzofuran potassium channel blockers and uses thereof |
| 04/10/2008 | WO2008040043A1 Process for the preparation of pleuromutilins |
| 04/10/2008 | WO2008028141A3 Raf inhibitor compounds and methods of use thereof |
| 04/10/2008 | WO2008027523A3 Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 04/10/2008 | WO2008024494A3 Pharmacokinetically improved compounds |
| 04/10/2008 | WO2008021804A3 Therapeutic amides and related compounds |
| 04/10/2008 | WO2008021364A3 Triazole compounds that modulate hsp90 activity |
| 04/10/2008 | WO2008020256A3 3,4-dihydrobenzo[1,2,3]thiadiazine-1,1-dioxide derivatives, process for preparation thereof, medicaments containing said derivatives and their use |
| 04/10/2008 | WO2008020040A3 2,5-dihydroxybenzene compounds for the treatment of fibrosis |
| 04/10/2008 | WO2008020027A3 2,5-dihydroxybenzene compounds for the treatment of skin cancer |
| 04/10/2008 | WO2008017658A3 Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 04/10/2008 | WO2008017024A3 Method of treating chronic myelogenous leukemia cells |
| 04/10/2008 | WO2008016596A3 Pseudobase benzo [c] phenanthridines with improved efficacy, stability, and safety |
| 04/10/2008 | WO2008016547A3 Aurora kinase inhibitors from an encoded small molecule library |
| 04/10/2008 | WO2008015578A3 Antitumor compositions containing acetylcyclopropyl docetaxel and trastuzumab |
| 04/10/2008 | WO2008014505A3 Blends for improved solubilization of active and functional organic compounds |
| 04/10/2008 | WO2008014497A3 Aldh-2 inhibitors in the treatment of addiction |
| 04/10/2008 | WO2008013988A9 Method of treating a condition associated with phosphorylation of task-1 |
| 04/10/2008 | WO2008012361A3 Dimethano-[1,3] dioxocino [6,5-d] pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain |
| 04/10/2008 | WO2008012110A3 Annellated pyrrole compounds for cancer management |
| 04/10/2008 | WO2008008770A3 6, 9-disubstituted purine derivatives and their use for treating skin |
| 04/10/2008 | WO2008008701B1 Substituted cyclopentane derivatives as therapeutic agents |
| 04/10/2008 | WO2008007131A3 Treatment for demyelinating disease |
| 04/10/2008 | WO2008006528A3 Pharmaceutical compositions comprising levetiracetam |
| 04/10/2008 | WO2008006044A3 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 04/10/2008 | WO2008005569A3 Modulators of metabolism and the treatment of disorders related thereto |
| 04/10/2008 | WO2008005352A3 Solid dose formulations of a thrombin receptor antagonist |
| 04/10/2008 | WO2008005303A3 Thiazolopyrimidine modulators of trpv1 |
| 04/10/2008 | WO2008003702A3 Fused bicyclic compounds interacting with the histamine h4 receptor |
| 04/10/2008 | WO2008002959A3 Hiv integrase inhibitors |
| 04/10/2008 | WO2007150074A3 Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007146115A3 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts |
| 04/10/2008 | WO2007144652A3 Parp inhibitors |
| 04/10/2008 | WO2007144394A3 Pharmaceutical use of substituted piperidine carboxamides |
| 04/10/2008 | WO2007144327A3 Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands |
| 04/10/2008 | WO2007143597A3 Organic compounds |
| 04/10/2008 | WO2007142842A3 Combination of anti-inflammatory steroids having transporter-enhanced corticosteroid activity |
| 04/10/2008 | WO2007141306A3 Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist |
| 04/10/2008 | WO2007140917A3 CRYSTALLINE FORMS OF 11 ß-(4-ACETYLPHENYL)-20,20,21,21,21-PENTAFLUOR-17- HYDROXY-19-NOR-17α-PREGNA-4,9-DIEN-3-ONE |
| 04/10/2008 | WO2007137874A3 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
| 04/10/2008 | WO2007137129A3 RNAI-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR α-RELATED CONDITIONS |
| 04/10/2008 | WO2007136875A3 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/10/2008 | WO2007135703A3 Patch for the treatment of the cellulite and localized adiposity |
| 04/10/2008 | WO2007129221A8 Compositions comprising an epi-inositol compounds and methods for treatment of disorders of protein aggregation |
| 04/10/2008 | WO2007125105A3 Benzamide glucokinase activators |
| 04/10/2008 | WO2007125103A3 Benzamide glucokinase activators |
| 04/10/2008 | WO2007122635B1 Controlled release formulation comprising anti-epileptic drugs |
| 04/10/2008 | WO2007121918A3 Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine a2a receptor agonists |
| 04/10/2008 | WO2007120374A3 Anti-arenaviral compounds |
| 04/10/2008 | WO2007118996A3 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis |
| 04/10/2008 | WO2007117849A3 Use of inhibitors of jun n-terminal kinases to treat glaucoma |
| 04/10/2008 | WO2007115289A3 Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer |
| 04/10/2008 | WO2007110868A3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 04/10/2008 | WO2007105190A9 Amyloid and amyloid-like structures |
| 04/10/2008 | WO2007105071A3 Composition for cosmetic or pharmaceutical-dermatological use |
| 04/10/2008 | WO2007102888A3 Methods of treating cancer with doxazolidine and prodrugs thereof |
| 04/10/2008 | WO2007101111A3 Methods of treating influenza viral infections |
| 04/10/2008 | WO2007100766A3 Health bars and compositions for improving cardiovascular risk factors |
| 04/10/2008 | WO2007098240A3 Compositions to reduce blood glucose levels and treat diabetes |
| 04/10/2008 | WO2007092535A3 4-acylaminopyridine derivative mediated neurogenesis |
| 04/10/2008 | WO2007092469A3 Combination of organic compounds |
| 04/10/2008 | WO2007089673A8 Compositions and methods for treatment of ophthalmic diseases and disorders |
| 04/10/2008 | WO2007089511A3 Fast acting inhibitor of gastric acid secretion |
| 04/10/2008 | WO2007089445A3 Ang2 and vegf inhibitor combinations |
| 04/10/2008 | WO2007087064A3 Pneumococcal serotypes |
| 04/10/2008 | WO2007065662A3 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 04/10/2008 | WO2007061752A3 Biocompatible latent emulsifiers |
| 04/10/2008 | WO2007060448A3 Chemical process for the preparation of an amido-phenoxybenzoic acid compound |
| 04/10/2008 | WO2007057762A3 Osmotic bi-layer tablet |
| 04/10/2008 | WO2007024653A3 Method and substances for isolating micro rnas |
| 04/10/2008 | WO2007019180A3 Compounds for binding to eralpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof |
| 04/10/2008 | WO2007015280A8 Benzodiazepine derivatives and uses thereof in medical field |
| 04/10/2008 | WO2007003525A3 Cyclic anilino-pyridinotriazines as gsk-3 inhibitors |
| 04/10/2008 | WO2006138466B1 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules |
| 04/10/2008 | WO2006123314A3 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
| 04/10/2008 | WO2006096405A8 Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues |
| 04/10/2008 | WO2006065968A3 The uses of estrogen beta agonists to treat cognitive diseases |
| 04/10/2008 | WO2005007875A3 Enhanced promoters for synthesis of small hairpin rna |